Free Trial

Oracle Corporation (NYSE:ORCL) Shares Bought by Sumitomo Mitsui Trust Group Inc.

Oracle logo with Computer and Technology background

Sumitomo Mitsui Trust Group Inc. increased its position in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 1.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,481,900 shares of the enterprise software provider's stock after purchasing an additional 73,061 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned 0.16% of Oracle worth $626,614,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in ORCL. Norges Bank acquired a new stake in shares of Oracle during the 4th quarter worth approximately $2,216,314,000. Raymond James Financial Inc. acquired a new stake in Oracle in the fourth quarter worth $930,095,000. GAMMA Investing LLC increased its position in Oracle by 15,012.3% in the first quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider's stock worth $664,810,000 after buying an additional 4,723,631 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Oracle by 20.5% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider's stock valued at $2,303,858,000 after buying an additional 2,350,448 shares during the last quarter. Finally, Vanguard Group Inc. boosted its holdings in shares of Oracle by 1.5% during the fourth quarter. Vanguard Group Inc. now owns 157,411,949 shares of the enterprise software provider's stock valued at $26,231,127,000 after acquiring an additional 2,296,069 shares during the period. Institutional investors and hedge funds own 42.44% of the company's stock.

Oracle Trading Down 1.2%

Oracle stock opened at $210.16 on Friday. Oracle Corporation has a 52 week low of $118.86 and a 52 week high of $216.93. The company has a debt-to-equity ratio of 4.07, a quick ratio of 0.75 and a current ratio of 0.75. The firm has a market capitalization of $590.31 billion, a price-to-earnings ratio of 48.42, a P/E/G ratio of 3.19 and a beta of 1.32. The company has a 50 day moving average price of $168.42 and a 200 day moving average price of $162.36.

Oracle (NYSE:ORCL - Get Free Report) last issued its earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, topping the consensus estimate of $1.64 by $0.06. The business had revenue of $15.90 billion during the quarter, compared to analysts' expectations of $15.58 billion. Oracle had a return on equity of 87.34% and a net margin of 21.68%. Oracle's revenue was up 11.3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.63 earnings per share. Research analysts forecast that Oracle Corporation will post 5 EPS for the current year.

Oracle Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 24th. Stockholders of record on Thursday, July 10th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.95%. The ex-dividend date of this dividend is Thursday, July 10th. Oracle's dividend payout ratio is currently 46.08%.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Loop Capital set a $135.00 price objective on shares of Oracle in a report on Tuesday, June 10th. Piper Sandler restated a "neutral" rating and issued a $130.00 target price on shares of Oracle in a research report on Wednesday, June 11th. Citigroup reaffirmed an "outperform" rating on shares of Oracle in a report on Thursday, June 12th. JPMorgan Chase & Co. boosted their price objective on Oracle from $135.00 to $185.00 and gave the stock a "neutral" rating in a research report on Thursday, June 12th. Finally, Jefferies Financial Group raised their target price on Oracle from $190.00 to $200.00 and gave the company a "buy" rating in a research report on Monday, June 9th. Eleven analysts have rated the stock with a hold rating, twenty-one have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $197.67.

Check Out Our Latest Research Report on Oracle

Insider Activity

In other Oracle news, insider Clayton M. Magouyrk sold 15,000 shares of the company's stock in a transaction dated Tuesday, June 17th. The stock was sold at an average price of $214.10, for a total value of $3,211,500.00. Following the transaction, the insider now directly owns 60,722 shares of the company's stock, valued at $13,000,580.20. This represents a 19.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Naomi O. Seligman sold 2,000 shares of the firm's stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $145.81, for a total value of $291,620.00. Following the sale, the director now directly owns 34,630 shares of the company's stock, valued at $5,049,400.30. This trade represents a 5.46% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 442,366 shares of company stock worth $83,395,223 in the last ninety days. Corporate insiders own 42.20% of the company's stock.

Oracle Company Profile

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

See Also

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oracle Right Now?

Before you consider Oracle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.

While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines